Stanley Peart | |
---|---|
![]() Peart in 1987 | |
Born | William Stanley Peart 31 March 1922 South Shields, County Durham, England |
Died | 14 March 2019 96) Highgate, London, England | (aged
Father | Jack Peart |
Awards |
|
Scientific career | |
Fields |
Sir William Stanley Peart FMedSci FRS [1] (31 March 1922 [2] – 14 March 2019) was a British medical doctor and clinical researcher who was first to demonstrate the release of noradrenaline after the stimulation of sympathetic nerves. [3]
Peart was the son of footballer and Fulham Football Club manager John George Peart and Margaret Joan (née Fraser). [4] [5]
Peart was educated at King's College School Bradford Grammar School and St Mary's Hospital Medical School (now part of Imperial College School of Medicine). [6]
Peart's main research interest lay in renal medicine and in particular, a hormone system that regulates blood pressure and water called the renin–angiotensin system.
He was the first to purify the peptide hormone angiotensin and determine its structure. He later isolated the enzyme renin — which catalyses the production of angiotensin — and carried out work to investigate the control of its release in the body. Peart is also acknowledged as being the driving force behind the development of the renal transplant programme at St Mary's Hospital in Paddington, London.
Peart was Chair of the Medical Research Society for more than a decade and later a member of the Medical Research Council. He was also a trustee of the Wellcome Trust, where he headed their first clinical panel. [3]
Peart was elected a Fellow of the Royal Society (FRS) in 1969. He was knighted in 1985. [3] He was elected a member of the Academia Europaea in 1989. [7] He was awarded the Buchanan Medal of the Royal Society in 2000 "for his contribution to the foundations of understanding of the renin angiotensin system in particular through his seminal work on the isolation and determination of the structure of angiotensin, purification of renin, and subsequent studies on the control of renin release". [8]
In 1947, [9] Peart married Peggy Parkes, a nurse at St Mary's Hospital. [4]
Peart, Stanley; Blythe, Max (1993). "Sir Stanley Peart FRS in interview with Dr Max Blythe: Interview 1, Part 1". Medical Sciences Video Archive. Oxford Brookes University. doi:10.24384/000236 . Retrieved 9 March 2020.
Peart, Stanley; Blythe, Max (1993). "Sir Stanley Peart FRS in interview with Dr Max Blythe: Interview 1, Part 2". Medical Sciences Video Archive. Oxford Brookes University. doi:10.24384/000057 . Retrieved 9 March 2020.
Peart, Stanley; Blythe, Max (1994). "Sir Stanley Peart FRS in interview with Dr Max Blythe: Interview 2". Medical Sciences Video Archive. Oxford Brookes University. doi:10.24384/000055 . Retrieved 9 March 2020.
Peart, Stanley; Asconas, Ita (1994). "Sir Stanley Peart FRS in interview with Dr Ita Askonas FRS: Interview 3". Medical Sciences Video Archive. Oxford Brookes University. doi:10.24384/000234 . Retrieved 9 March 2020.
Peart, Stanley; Blythe, Max (1995). "Sir Stanley Peart FRS in interview with Dr Max Blythe: Interview 4". Medical Sciences Video Archive. Oxford Brookes University. doi:10.24384/000056 . Retrieved 9 March 2020.
Peart, Stanley; Asconas, Ita (1995). "Sir Stanley Peart FRS in interview with Dr Max Blythe: Interview 5". Medical Sciences Video Archive. Oxford Brookes University. doi:10.24384/000235 . Retrieved 9 March 2020.
Angiotensin-converting-enzyme inhibitors are a class of medication used primarily for the treatment of high blood pressure and heart failure. This class of medicine works by causing relaxation of blood vessels as well as a decrease in blood volume, which leads to lower blood pressure and decreased oxygen demand from the heart.
Dorothy Mary Crowfoot Hodgkin was a Nobel Prize-winning English chemist who advanced the technique of X-ray crystallography to determine the structure of biomolecules, which became essential for structural biology.
The renin-angiotensin system (RAS), or renin-angiotensin-aldosterone system (RAAS), is a hormone system that regulates blood pressure, fluid, and electrolyte balance, and systemic vascular resistance.
Angiotensin is a peptide hormone that causes vasoconstriction and an increase in blood pressure. It is part of the renin–angiotensin system, which regulates blood pressure. Angiotensin also stimulates the release of aldosterone from the adrenal cortex to promote sodium retention by the kidneys.
The angiotensin II receptors, (ATR1) and (ATR2), are a class of G protein-coupled receptors with angiotensin II as their ligands. They are important in the renin–angiotensin system: they are responsible for the signal transduction of the vasoconstricting stimulus of the main effector hormone, angiotensin II.
Sir John Robert Vane was a British pharmacologist who was instrumental in the understanding of how aspirin produces pain-relief and anti-inflammatory effects and his work led to new treatments for heart and blood vessel disease and introduction of ACE inhibitors. He was awarded the Nobel Prize in Physiology or Medicine in 1982 along with Sune Bergström and Bengt Samuelsson for "their discoveries concerning prostaglandins and related biologically active substances".
Renal artery stenosis (RAS) is the narrowing of one or both of the renal arteries, most often caused by atherosclerosis or fibromuscular dysplasia. This narrowing of the renal artery can impede blood flow to the target kidney, resulting in renovascular hypertension – a secondary type of high blood pressure. Possible complications of renal artery stenosis are chronic kidney disease and coronary artery disease.
Sir Walter Fred Bodmer is a German-born British human geneticist.
Renovascular hypertension is a condition in which high blood pressure is caused by the kidneys' hormonal response to narrowing of the arteries supplying the kidneys. When functioning properly this hormonal axis regulates blood pressure. Due to low local blood flow, the kidneys mistakenly increase blood pressure of the entire circulatory system. It is a form of secondary hypertension - a form of hypertension whose cause is identifiable.
Dame Alice Josephine Mary Taylor Barnes,, known professionally as Dr Josephine Barnes, was a leading English obstetrician and gynaecologist. She was the first female president of the British Medical Association, 1979. Barnes was active in the Women's National Cancer Control Campaign with cancer screening.
Dame Bridget Margaret Ogilvie, is an Australian and British scientist.
Angiotensin II receptor type 1(AT1) is a Gq/11-coupled G protein-coupled receptor (GPCR) and the best characterized angiotensin receptor. It is encoded in humans by the AGTR1 gene. AT1 has vasopressor effects and regulates aldosterone secretion. It is an important effector controlling blood pressure and volume in the cardiovascular system. Angiotensin II receptor blockers are drugs indicated for hypertension, diabetic nephropathy and congestive heart failure.
Brigitte Alice Askonas was a British immunologist and a visiting professor at Imperial College London from 1995.
Max Leonard Rosenheim, Baron Rosenheim, KBE, PRCP, FRS was a British physician and academic.
Jeremiah Noah Morris was a Scottish epidemiologist who established the importance of physical activity in preventing cardiovascular disease.
Glomerular hyperfiltration is a situation where the filtration elements in the kidneys called glomeruli produce excessive amounts of pro-urine. It can be part of a number of medical conditions particularly diabetic nephropathy.
Aileen Kirkpatrick Adams is a British retired consultant anaesthetist. She turned 100 in September 2023.
Pierre Corvol is a French doctor and biology researcher. He was director of the Collège de France from 2006 to August 2012.
Page kidney or Page phenomena is a potentially reversible form of secondary arterial hypertension caused by external compression of the renal parenchyma by some perirenal process. Any process that causes mass effect can be a potential cause of Page kidney. Hematomas, urinomas, tumors, cysts, lymphoceles, and aneurysms have all been reported in the literature. The compression is believed to cause activation of the renin–angiotensin–aldosterone system (RAAS) via microvascular ischemia.